OPIANT PHARMACEUTICALS, INC. License Agreements
11 Contracts & Agreements
- Amendment No. 2 to License Agreement, dated March 18, 2019, by and between Registrant and Adapt Pharma Operations Limited (Filed With SEC on March 21, 2019)
- License Agreement between the Company and Sanofi dated December 21, 2018 (Filed With SEC on December 28, 2018)
- License Agreement between the Company and Adapt Pharma Operations Limited, dated as of December 15, 2014 (Filed With SEC on March 5, 2018)
- License Agreement, dated as of June 22, 2017, by and between the Company and Aegis Therapeutics, LLC (Filed With SEC on October 13, 2017)
- AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on April 19, 2017)
- LICENSE AGREEMENT between LIGHTLAKETHERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15, 2014 (Filed With SEC on April 19, 2017)
- AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on March 15, 2017)
- Confidential AMENDMENTNO. 2 TOTHE MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENT EFFECTIVEAS OF DECEMBER 1, 2014 (Filed With SEC on October 26, 2015)
- LICENSE AGREEMENT between LIGHTLAKETHERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15, 2014 (Filed With SEC on October 26, 2015)
- LICENSE AGREEMENT between LIGHTLAKETHERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15 2014 (Filed With SEC on June 12, 2015)
- LICENSE AGREEMENT between LIGHTLAKETHERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15 2014 (Filed With SEC on March 17, 2015)
